1. Home
  2. Analysis
  3. Pantoprazole-sodium
  4. Diprivan

Pantoprazole sodium and Diprivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole sodium and Diprivan. Common interactions include chest pain among females and septic shock among males.

The phase IV clinical study analyzes what interactions people who take Pantoprazole sodium and Diprivan have. It is created by eHealthMe based on reports of 39 people who take Pantoprazole sodium and Diprivan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

39 people who take Pantoprazole sodium and Diprivan together, and have interactions are studied.

What is Pantoprazole sodium?

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 44,375 Pantoprazole sodium users for its effectiveness, alternative drugs and more.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,276 Diprivan users for its effectiveness, alternative drugs and more.

Number of Pantoprazole sodium and Diprivan reports submitted per year:

Pantoprazole sodium and Diprivan drug interactions.

Common Pantoprazole Sodium and Diprivan drug interactions by gender *:

female:

  1. Chest pain
  2. Convulsion
  3. Dyspnoea
  4. Erythema
  5. Failure to thrive
  6. Fall
  7. Heart rate decreased
  8. Hepatic enzyme increased
  9. Hepatic steatosis
  10. Hip arthroplasty

male:

  1. Septic shock
  2. Hepatic failure
  3. Hypotension
  4. Intraventricular haemorrhage
  5. Jaundice
  6. Multi-organ failure
  7. Ventricular dysfunction
  8. Waterhouse-friderichsen syndrome
  9. Abdominal pain upper
  10. Bacteraemia

Common Pantoprazole Sodium and Diprivan drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Septic shock
  2. Agranulocytosis
  3. Pancytopenia
  4. Histiocytosis haematophagic
  5. Infectious mononucleosis
  6. Atrial fibrillation
  7. Cardiac failure
  8. Cerebral infarction
  9. Disseminated intravascular coagulation
  10. Ejection fraction decreased

20-29:

  1. Propofol infusion syndrome
  2. Ventricular tachycardia

30-39:

  1. Lipase increased
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Pancreatitis
  5. Blood amylase increased

40-49:

  1. Anaphylactic reaction
  2. Hypotension
  3. Oxygen saturation decreased
  4. Urticaria

50-59:

  1. Drug ineffective
  2. Hepatic failure
  3. Renal failure
  4. Septic shock
  5. Multi-organ failure
  6. Anaphylactic shock
  7. Anuria
  8. Bacterial infection
  9. Blister
  10. Blood potassium decreased

60+:

  1. Jaundice
  2. Abdominal pain upper
  3. Cholestasis
  4. Confusional state
  5. Hypotension
  6. Ileus
  7. Acute pulmonary oedema
  8. Blood albumin decreased
  9. Blood creatinine increased
  10. Blood urea increased

Common conditions people have *:

  1. Sedation: 9 people, 23.08%
  2. Escherichia Infection (bacterial infection by escherichia coli): 4 people, 10.26%
  3. Anaesthesia: 4 people, 10.26%
  4. Pain: 4 people, 10.26%
  5. High Blood Pressure: 4 people, 10.26%
  6. General Anaesthesia: 4 people, 10.26%
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 10.26%
  8. Hypersensitivity: 3 people, 7.69%
  9. Pneumonia Staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus): 3 people, 7.69%
  10. Nausea (feeling of having an urge to vomit): 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole sodium and Diprivan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Pantoprazole sodium and Diprivan interactions:

Browse all drug interactions of Pantoprazole sodium and Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pantoprazole sodium side effects:

Browse all side effects of Pantoprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Diprivan side effects:

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pantoprazole sodium interactions:

Browse all interactions between Pantoprazole sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Diprivan interactions:

Browse all interactions between Diprivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and propofol (the active ingredients of Pantoprazole sodium and Diprivan, respectively), and Pantoprazole sodium and Diprivan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pantoprazole sodium and Diprivan.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.